Prediction of uterine myoma growth rate: what's new? (Literature review)
DOI:
https://doi.org/10.12775/JEHS.2024.52.111Keywords
epigenetics, microRNAs, uterine fibroids, prognosisAbstract
Uterine fibroid remains a relevant issue in modern gynecology and reproductive medicine as the most common benign tumor of the female reproductive organs. Comprehensive diagnosis of the condition of the myomatous nodule and its potential growth rate plays a significant role in the rational selection of treatment tactics for women of reproductive age with uterine fibroids.
Objective. To study and analyze existing methods of diagnosis and prediction the growth of uterine fibroids.
Matherials and methods. Information search was conducted in the scientific literature in domestic and foreign publications, 46 sources were studied and analyzed. In the course of the study, a meta-analysis of the information obtained was carried out as to the set goal.
Results and discussion. At present, at least three main mechanisms of activation of signal pathways stimulating leiomyocyte to pathological growth and division have been elucidated: cytokines, growth factors, and hormone-dependent channels. All links in the activation of signal pathways affecting the cell, which subsequently lead to pathological proliferation and tumor transformation, are interconnected. In recent years, the pathogenesis of uterine fibroids has been actively studied not only at the tissue level but also at the genetic and epigenetic levels. It has been definitively proven that disturbances in microRNAs, both tissue-specific and stable, play a leading role in regulating the expression of key genes associated with the pathogenesis of uterine leiomyomas, both in tumor foci and in biological fluids. Conclusions. Study of the expression of microRNAs is a promising method for understanding the further development of the pathological process and for predicting the growth of uterine fibroids.
References
Yang Q, Ciebiera M, Bariani MV et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022; 43(4):678-719. doi: 10.1210/endrev/bnab039
Grube M, Neis F, Brucker SY et al. Uterine Fibroids - Current Trends and Strategies. Surg. Technol Int. 2019; 34:257-263. Available from: https://pubmed.ncbi.nlm.nih.gov/30888674/
Giuliani E, As-Sanie S, Marsh E.E. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020; 149(1):3-9. doi: 10.1002/ijgo.13102.
Pavone D, Clemenza S, Sorbi F et al. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res. Clin Obstet. Gynaecol. 2018; 46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004.
Laughlin-Tommaso SK, Fuchs EL, Wellons MF et al. Uterine Fibroids and the Risk of Cardiovascular Disease in the Coronary Artery Risk Development in Young Adult Women's Study. J Womens Health (Larchmt). 2019; 28(1):46-52. doi: 10.1089/jwh.2018.7122.
Ulin M, Ali M, Chaudhry ZT et al. Uterine fibroids in menopause and perimenopause. Menopause. 2020;27(2):238-242. doi: 10.1097/GME.0000000000001438.
Rozhkovska N.M, Zhelezov D.M, Kossei T.V. Prediction of uterine fibroids recurrence during pregnancy. Bulletin of Scientific Research. 2017; 2:127-130. (in Ukrainian). https://doi.org/10.11603/2415-8798.2017.2.7848
Krut Yu.Ya, Zemliana N.A. Clinical anamnestic and immunoenzymatic predictors of recurrence of endometrial hyperplastic processes in combination with uterine fibroids. Reproductive health of women. 2020; 5:48-52. (in Ukrainian)https://doi.org/10.30841/2708-8731.5.2021.224498
Li Q, Zhong J, Yi D. Assessing the risk of rapid fibroid growth in patients with asymptomatic solitary uterine myoma using a multivariate prediction model. Ann Transl Med. 2021; 9(5):370 doi: 10.21037/atm-20-4559.
Zhelezov D.M, Kossei T.V. Prediction the growth of uterine fibroids in the pregravid period [Electronic resource]. Odesa Medical Journal. 2017;1:41-45. (in Ukrainian). Available from: http://repo.odmu.edu.ua:80/xmlui/handle/123456789/1517
Zaporozhan V.M, Tsehelskyi M.R. Gynecological pathology: Atlas: Study guide. Odesa: Odesa State Medical University; 2002. 308 p.
Zaporozhchenko M.B. Pathogenetic treatment of proliferative type uterine fibroids in women of reproductive age: dissertation on the development of the scientific level of Doctor of Medical Sciences: specialization 14.01.01 «Obstetrics and gynecology». Odesa, 2015. 365 p.
Duhan N, Sirohiwal D. Uterine myomas revisited. European journal of obstetrics, gynecology, and reproductive biology. 2010; 152(2):119—125. Available from:https://pubmed.ncbi.nlm.nih.gov/20933150/
Ramdass M.J, Rambocas N, Hosein Y et al. Parasitic Uterine Leiomyoma with Arteriovenous Malformation, Portal Hypertension, and Cardiac Failure. J Obstet Gynaecol Can. 2023 May; 45(5):295-296. doi: 10.1016/j.jogc.2021.08.012.
Barik A, Singh V. Curious Case of Parasitic Fibroid in a Postmenopausal Woman. Cureus. 2022 May 16; 14(5):e25048. doi: 10.7759/cureus.25048.
Gladchuk I.Z, Salekh O.S. Clinical observation of benign metastatic leiomyoma. Klinicheskaia khirurgiia. 2022; 89(11-12):61-63 (in Ukrainian) https://doi.org/10.26779/2522-1396.2022.11-12.61.
Lubiana S.S, Shelyhin M.S. Features of cytokine production by peripheral blood lymphocytes in women with uterine fibroids. Ukrainian Medical Almanac. 2006; 9(4) (supplement):681–684.
McWilliams M.M, Chennathukuzhi V.M. Recent Advances in Uterine Fibroid Etiology. Semin Reprod Med. 2017; 35(2):181-189. doi: 10.1055/s-0037-1599090. 19. Bariani M.V, Rangaswamy R, Siblini H et al. The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis. Curr Opin Endocrinol Diabetes Obes.2020; 27(6):380-387. doi: 10.1097/MED.0000000000000578.
Kirschen G.W, AlAshqar A, Miyashita-Ishiwata M et al. Vascular biology of uterine fibroids: connecting fibroids and vascular disorders. Reproduction. 2021; 162(2):1-18. doi: 10.1530/REP-21-0087.
Dueholm M. Fibroid vascularisation as a predictor for uterine fibroid growth. BJOG. 2018; 125(5):585 doi: 10.1111/1471-0528.14727.
Nieuwenhuis L.L, Keizer A.L, Stoelinga B et al. Fibroid vascularisation assessed with three-dimensional power Doppler ultrasound is a predictor for uterine fibroid growth: a prospective cohort study. BJOG. 2018; 125(5):577-584. doi: 10.1111/1471-0528.14608.
Awiwi M.O, Badawy M, Shaaban AM et al. Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification. Abdom Radiol (NY). 2022; 47(7): 2468-2485. doi: 10.1007/s00261-022-03545-x.
Jondal D.E, Wang J, Chen J. Uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography. Abdom Radiol (NY). 2018; 43(6):1456-1463. doi: 10.1007/s00261-017-1314-1.
Pakrashi T. New hysteroscopic techniques for submucosal uterine fibroids. Curr Opin Obstet Gynecol. 2014; 26(4):308-13. doi: 10.1097/GCO.0000000000000076.
Bosteels J, van Wessel S, Weyers S et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev. 2018; 12(12). CD009461. doi: 10.1002/14651858.CD009461.pub4.
Makris N, Vomyolaki E, Mantxaris G et al. Role of a bipolar resectoscope in subfertile women with submucous myomas and menstrual disorder. The journal of obstetrics and gynaecology research. 2007; 33(6):849—854. DOI: 10.1111/j.1447-0756.2007.00667.x
Bulun S.E, Lin Z, Imir G. Regulation of Aromatase Expression in Estrogen Responsive Breast and Uterine Disease: From Bench to Treatment. Pharmacological reviews. 2005; 57(3):359—383. DOI: 10.1124/pr.57.3.6
MacLean J.A 2nd, Hayashi K. Progesterone Actions and Resistance in Gynecological Disorders. Cells. 2022; 11(4):647 doi: 10.3390/cells11040647.
Daniels J, Middleton L.J, Cheed V et al. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technol Assess. 2022; 26(22):1-74. doi: 10.3310/ZDEG6110.
Thuring A, Laurini R, Marsál K. Uterine venous blood flow in normal and complicated pregnancies: a methodological study. Ultrasound Obstet Gynecol.2010; 35(4):462-467. doi: 10.1002/uog.7572.
Browne V.A, Toledo-Jaldin L, Davila R.D et al. High-end arteriolar resistance limits uterine artery blood flow and restricts fetal growth in preeclampsia and gestational hypertension at high altitude. Am J Physiol Regul Integr Comp Physiol.2011; 300(5):1221-1229. doi: 10.1152/ajpregu.91046.2008.
Szpera-Goździewicz A, Gruca-Stryjak K, Bręborowicz GH. Uterine arteriovenous malformation - diagnosis and management. Ginekol Pol. 2018; 89(5):276-279. doi: 10.5603/GP.a2018.0047.
Yang Q, Ciebiera M, Bariani M.V et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev.2022;43(4):678-719. doi: 10.1210/endrev/bnab039.
Machado-Lopez A, Simón C, Mas A. Molecular and Cellular Insights into the Development of Uterine Fibroids. Int J Mol Sci. 2021; 22(16):8483 doi: 10.3390/ijms22168483.
Yang Q, Mas A, Diamond M.P et al. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development. Reprod Sci. 2016; 23(2):163-175. doi: 10.1177/1933719115584449.
Islam M.S, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018; 24(1):59-85. doi: 10.1093/humupd/dmx032.
Ali M, Esfandyari S, Al-Hendy A. Evolving role of microRNAs in uterine fibroid pathogenesis: filling the gap! Fertil Steril. 2020; 113(6):1167-1168. doi: 10.1016/j.fertnstert.2020.04.011.
Tinelli A, Catherino W.H, Gargiulo A.R. Uterine Fibroids: From Molecular Oncology to Reproduction. Biomed Res Int. 2018 Sep 3; 6284875. doi: 10.1155/2018/6284875.
Ligon A.H, Morton C.C. Genetics of uterine leiomyomata. Genes Chromosomes Cancer. 2000; 28(3):235-45. Available from: https://pubmed.ncbi.nlm.nih.gov/10862029/
Katz T.A, Yang Q, Treviño L.S et al. Endocrine-disrupting chemicals and uterine fibroids. Fertil Steril. 2016; 106(4):967-977. doi: 10.1016/j.fertnstert.2016.08.023.
Kuzomenska M, Chyrva S. Analysis of current views on uterine fibroids and treatment methods. Women’s reproductive health. 2021; 3:41–47. (in Ukrainian) https://doi.org/10.30841/2708-8731.3.2021.234243.
Cheng Y, Dong L, Zhang J et al. Recent advances in microRNA detection. Analyst. 2018; 143(8):1758-1774. DOI: 10.1039/C7AN02001E
Chuang T.D, Khorram O. Mechanisms underlying aberrant expression of miR-29c in uterine leiomyoma. Fertility and sterility. 2016; 105(1):236-245. DOI: 10.1016/j.fertnstert.2015.09.020
Yang E, Xue L, Li Z et al. Lnc-AL445665. 1–4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p. BMC cancer. 2019; 19(1):1-11. doi: 10.1186/s12885-019-5775-1
Marsh E.E, Steinberg M.L, Parker J.B et al. Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production. Fertility and sterility. 2016; 106(3): 766-772. DOI: 10.1016/j.fertnstert.2016.05.001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 I. Gladchuk, O. Salekh
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 102
Number of citations: 0